NPPA caps ceiling prices of 12 anti-diabetic drugs, Details Medical Dialogues Team26 Oct 2021 5:00 PM ISTTo make it possible for every Indian to afford medical treatment against diseases like diabetes, NPPA has initiated a successful step by fixing the...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
After selling Humalog, Trulicity rights to Cipla, Eli Lilly sacks 120 staff in India: Report Medical Dialogues Team11 Oct 2021 5:46 PM ISTNew Delhi: After transferring the rights to sell popular anti-diabetes drugs Humalog and Trulicity to Mumbai-based Cipla, Eli Lilly, a global...
Glenmark gets CDSCO panel nod to study antidiabetic drug Lobeglitazone Sulfate Medical Dialogues Team6 Oct 2021 6:26 PM ISTNew Delhi: In a significant development, drug firm Glenmark has got a green signal from the Subject Expert Committee (SEC) functional under the...
Sanofi gets CDSCO panel marketing authorization for Insulin Glargine Medical Dialogues Team3 Oct 2021 11:30 AM ISTNew Delhi: Approving the waiver of additional requirements for local clinical trials in the country, the Subject Expert Committee (SEC) functional...
NPPA fixes retail price of 19 formulations including Metformin, Dapagliflozin, Details Medical Dialogues Team27 Aug 2021 1:45 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Mankind Pharma Medical Dialogues Team25 Jun 2021 5:22 PM ISTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, Dapagliflozin to consumers, the National Pharmaceutical Pricing...
Two groups of blood sugar control drugs significantly reduce CKD and CVD risk- AHA Dr. Kamal Kant Kohli29 Sept 2020 8:00 AM ISTDALLAS - Two newer groups of antidiabetic medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor...
SGLT2 inhibitors with metformin do not increase fracture risk in diabetics: Study Medha Baranwal21 Aug 2020 11:15 AM ISTChina: Combination therapy with SGLT2 inhibitors and metformin in patients with type 2 diabetes (T2D) does not increase fracture risk versus metformin...
Covid-19 impact: Sale of cardiac, anti-diabetic drugs surge Ruchika Sharma18 July 2020 3:21 PM ISTThe sudden change in preferred therapies by masses has just taken a sharp turn from pre-Covid period when gastric, vitamin therapies were most widely...
Novartis to pay over Rs 5064 crore to settle alleged doctor-bribe, price-fixing claims Farhat Nasim3 July 2020 12:07 PM ISTThe company admitted giving doctors cash, golf and fishing trips, and lavish meals at some of the nation's fanciest restaurants to induce them to...
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby Khatun Khatun31 Aug 2018 9:00 AM ISTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
